Home
>
US Stocks
>
Sigilon Therapeutics Inc
Sigilon Therapeutics Inc
SGTX

Sigilon Therapeutics Inc (SGTX)

$5.813.2%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.61
Today Low/High
5.61 / 5.88
52 Week Low/High
$4.75 / $54.32
Market Cap
$158.68M

Company Details

Sigilon Therapeutics seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform. Sigilon’s product candidates are non-viral engineered cell-based therapies designed to produce the crucial proteins, enzymes or factors needed by patients living with chronic diseases such as hemophilia, lysosomal disorders and diabetes. The engineered cells are protected by Sigilon’s Afibromer™ biomaterials matrix, which shields them from immune rejection and fibrosis. Sigilon was founded by Flagship Pioneering in conjunction with Daniel Anderson, Ph.D., and Robert Langer, Sc.D., of the Massachusetts Institute of Technology.
Organisation
Sigilon Therapeutics Inc

Discover more

Frequently Asked Questions

What is Sigilon Therapeutics Inc (SGTX) share price today?

Can Indians buy Sigilon Therapeutics Inc (SGTX) shares?

How can I buy Sigilon Therapeutics Inc (SGTX) shares from India?

Can Fractional shares of Sigilon Therapeutics Inc (SGTX) be purchased?

What are the documents required to start investing in Sigilon Therapeutics Inc (SGTX) stocks?

We are a SEBI registered investement advisor